NASDAQ:TMCI Treace Medical Concepts (TMCI) Stock Price, News & Analysis $7.72 -0.11 (-1.40%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$7.55▼$7.9650-Day Range$4.94▼$8.4552-Week Range$3.92▼$23.33Volume510,932 shsAverage Volume833,887 shsMarket Capitalization$478.72 millionP/E RatioN/ADividend YieldN/APrice Target$12.86 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Treace Medical Concepts alerts: Email Address Treace Medical Concepts MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside66.5% Upside$12.86 Price TargetShort InterestBearish10.62% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.56Based on 4 Articles This WeekInsider TradingAcquiring Shares$2.93 M Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.89) to ($0.82) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.46 out of 5 starsMedical Sector303rd out of 936 stocksSurgical & Medical Instruments Industry39th out of 101 stocks 4.0 Analyst's Opinion Consensus RatingTreace Medical Concepts has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 7 hold ratings, and no sell ratings.Amount of Analyst CoverageTreace Medical Concepts has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Treace Medical Concepts' stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted10.62% of the float of Treace Medical Concepts has been sold short.Short Interest Ratio / Days to CoverTreace Medical Concepts has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Treace Medical Concepts has recently increased by 17.97%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldTreace Medical Concepts does not currently pay a dividend.Dividend GrowthTreace Medical Concepts does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TMCI. Previous Next 2.0 News and Social Media Coverage News SentimentTreace Medical Concepts has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Treace Medical Concepts this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for TMCI on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Treace Medical Concepts to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 5.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Treace Medical Concepts insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,930,422.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders24.43% of the stock of Treace Medical Concepts is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions84.08% of the stock of Treace Medical Concepts is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Treace Medical Concepts' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Treace Medical Concepts are expected to grow in the coming year, from ($0.89) to ($0.82) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Treace Medical Concepts is -8.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Treace Medical Concepts is -8.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTreace Medical Concepts has a P/B Ratio of 3.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Treace Medical Concepts' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Treace Medical Concepts Stock (NASDAQ:TMCI)Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.Read More TMCI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TMCI Stock News HeadlinesJuly 2, 2024 | insidertrades.com3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace (TMCI)July 22, 2024 | americanbankingnews.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Hold" from AnalystsJuly 27, 2024 | DTI (Ad)Heard about the 72-Hour Profit Surge? Read this…One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…July 18, 2024 | globenewswire.comTreace to Report Second Quarter 2024 Financial Results on August 6, 2024July 17, 2024 | americanbankingnews.comTreace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $9.00June 14, 2024 | seekingalpha.comTreace Medical Concepts: Facing Increasing Competitive PressureJune 7, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCIJune 5, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCIJuly 27, 2024 | DTI (Ad)Heard about the 72-Hour Profit Surge? Read this…One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…May 30, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCIMay 28, 2024 | globenewswire.comTreace to Present at Truist Securities MedTech ConferenceMay 22, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCIMay 19, 2024 | 247wallst.comCEOs and Other Insiders Are Buying Shares of These 7 StocksMay 17, 2024 | msn.comUBS Downgrades Treace Medical Concepts (TMCI)May 17, 2024 | businesswire.comKirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)May 16, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCIMay 16, 2024 | markets.businessinsider.comUnveiling 6 Analyst Insights On Treace Medical ConceptsMay 15, 2024 | finance.yahoo.comDirector Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI)See More Headlines Receive TMCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Treace Medical Concepts and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today7/27/2024Next Earnings (Confirmed)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:TMCI CUSIPN/A CIK1630627 Webwww.treace.com Phone904-373-5940FaxN/AEmployees250Year FoundedN/APrice Target and Rating Average Stock Price Target$12.86 High Stock Price Target$27.50 Low Stock Price Target$6.00 Potential Upside/Downside+66.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-49,530,000.00 Net Margins-27.93% Pretax Margin-27.93% Return on Equity-39.66% Return on Assets-22.24% Debt Debt-to-Equity Ratio0.42 Current Ratio3.98 Quick Ratio3.22 Sales & Book Value Annual Sales$196.03 million Price / Sales2.44 Cash FlowN/A Price / Cash FlowN/A Book Value$2.24 per share Price / Book3.45Miscellaneous Outstanding Shares62,008,000Free Float46,859,000Market Cap$478.70 million OptionableOptionable Beta0.22 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. John T. Treace (Age 52)CEO, Founder & Director Comp: $1.09MMr. Mark L. Hair CPA (Age 54)Chief Financial Officer Comp: $599.7kMr. Aaron J. Berutti (Age 45)Senior Vice President of Sales Comp: $484.22kMr. Terry W. Lubben (Age 59)Senior Vice President of Operations Mr. Taylor EricksonChief Information & Security OfficerMs. Julie D. Dewey (Age 63)Chief Communications & Investor Relations Officer Mr. Scot M. Elder J.D. (Age 49)Chief Legal & Compliance Officer and Corporate Secretary Mr. Nathan MinnichSenior Vice President of MarketingMr. Daniel E. Owens (Age 52)Chief Human Resources Officer Dr. Sean F. Scanlan Ph.D. (Age 42)Chief Innovation Officer More ExecutivesKey CompetitorsOrganogenesisNASDAQ:ORGOBioventusNYSE:BVSAngioDynamicsNASDAQ:ANGOParagon 28NYSE:FNASmileDirectClubNASDAQ:SDCView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 18,721 shares on 7/26/2024Ownership: 0.260%Bensler LLCBought 35,511 shares on 7/26/2024Ownership: 0.057%Accredited Investors Inc.Bought 69,000 shares on 7/20/2024Ownership: 0.111%Nisa Investment Advisors LLCBought 9,245 shares on 7/20/2024Ownership: 0.015%CWM LLCBought 6,826 shares on 7/10/2024Ownership: 0.016%View All Insider TransactionsView All Institutional Transactions TMCI Stock Analysis - Frequently Asked Questions How have TMCI shares performed this year? Treace Medical Concepts' stock was trading at $12.75 at the beginning of 2024. Since then, TMCI stock has decreased by 39.5% and is now trading at $7.72. View the best growth stocks for 2024 here. How were Treace Medical Concepts' earnings last quarter? Treace Medical Concepts, Inc. (NASDAQ:TMCI) released its quarterly earnings results on Tuesday, May, 7th. The company reported ($0.30) EPS for the quarter, meeting the consensus estimate of ($0.30). The business's revenue was up 21.1% on a year-over-year basis. When did Treace Medical Concepts IPO? Treace Medical Concepts (TMCI) raised $150 million in an initial public offering on Friday, April 23rd 2021. The company issued 9,400,000 shares at $15.00-$17.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. Who are Treace Medical Concepts' major shareholders? Top institutional investors of Treace Medical Concepts include Bank of New York Mellon Corp (0.26%), Simplicity Wealth LLC (0.13%), Accredited Investors Inc. (0.11%) and Bensler LLC (0.06%). Insiders that own company stock include John T Treace, John R Treace, Thomas E Timbie, James T Treace, Richard W Mott, Sean F Scanlan, Deepti Jain, Daniel E Owens, Mark Hair, Scot Michael Elder, Aaron Berutti, F Barry Bays and Terry W Lubben. View institutional ownership trends. How do I buy shares of Treace Medical Concepts? Shares of TMCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TMCI) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
